Â鶹ÊÓƵ

Brad Stone’s second book offers a deep dive into Amazon's methods for success

Steve Clapham illustrates how to understand earnings estimates and use them to your advantage

The history of the Soviet German Democratic Republic reveals the benefits and shortfalls of state-owned drugmakers

As activists add to the pressure on the GlaxoSmithKline board ahead of a proposed demerger, Robin Hardy asks if it will create value for shareholders

Newly-listed consolidation platform has huge promise, but won’t turn a profit for years

As the UK emerges from lockdown, share prices are beginning to recover. But the burden of a big debt pile means that some companies may have rerated too strongly.

An internal investigation into Nestle’s products has raised some thorny questions about its future

Inflation will rise in the next few months. But – with some potential caveats – it is unlikely to stay high

Without government-provided stimulus, can the housebuilders keep delivering for their shareholders?

The ultimate guide to the core of the markets